News
Cancer Antibody Drug Conjugates Treatment Market USD 50 Billion Opportunity Says Kuick Research. Delhi, July 11, 2025 (GLOBE ...
The FDA has granted accelerated approval to Datroway for adults with previously-treated, locally advanced or metastatic EGFR-mutated NSCLC.
The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...
12d
SurvivorNet on MSNNew Hope for Patients With Advanced Lung Cancer: Datroway, A New FDA ApprovalA new treatment option, Datroway (datopotamab deruxtecan or Dato-DXd), is now available for people with non-small cell lung ...
Datroway is used to treat an advanced form of non-small cell lung cancer in adults who had received prior treatment.
Bangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation ...
Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...
Datroway (datopotamab deruxtecan) is the first TROP2-directed therapy approved for advanced lung cancer in the U.S.
FDA officials issued the import alerts Tuesday to prevent 58 models of Olympus devices used in urinary, respiratory, abdominal and pelvic procedures from reaching customers in the U.S.
AstraZeneca PLC (NASDAQ:AZN) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results